COGT vs. VISN

Last updated Jun 4, 2026

COGT (Cogent Biosciences, Inc.) and VISN (Vistance Networks, Inc) are both stocks. COGT operates in Biotechnology (Healthcare), while VISN operates in Communication Equipment (Technology). Over the past 5 years, COGT returned 32.16%/yr vs 20.42%/yr for VISN. At a 0.19 correlation, their price movements are largely independent.

Performance

COGT vs. VISN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cogent Biosciences, Inc. (COGT) and Vistance Networks, Inc (VISN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, COGT achieves a -9.18% return, which is significantly lower than VISN's 191.71% return.

COGT

• 1D: -1.53%
• 1M: -12.17%
• YTD: -9.18%
• 6M: -17.62%
• 1Y: 457.17%
• 3Y*: 35.49%
• 5Y*: 32.16%
• 10Y*: —

VISN

• 1D: -1.85%
• 1M: -1.21%
• YTD: 191.71%
• 6M: 178.06%
• 1Y: 781.44%
• 3Y*: 125.37%
• 5Y*: 20.42%
• 10Y*: 5.18%

*Multi-year figures are annualized to reflect compound growth (CAGR)

COGT vs. VISN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
COGT Cogent Biosciences, Inc.	-9.18%	355.38%	32.65%	-49.13%	34.73%	-23.60%	289.93%	-83.64%	-60.40%
VISN Vistance Networks, Inc	191.71%	247.98%	84.75%	-61.63%	-33.42%	-17.61%	-5.57%	-13.42%	-58.99%

Correlation

The correlation between COGT and VISN is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.18
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.20
Correlation (All Time) Calculated using the full available price history since Apr 2, 2018	0.19

Fundamentals

Market Cap COGT : $2.17B VISN : $2.75B
EPS COGT : -$3.89 VISN : $0.00
PB Ratio COGT : 3.76 VISN : 0.60
Total Revenue (TTM) COGT : $0.00 VISN : $4.00B
Gross Profit (TTM) COGT : -$2.33M VISN : $1.56B
EBITDA (TTM) COGT : -$363.18M VISN : $811.00M

Return for Risk

COGT vs. VISN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COGT

COGT Risk / Return Rank: 98
COGT Sharpe Ratio Rank: 96
COGT Sortino Ratio Rank: 99
COGT Omega Ratio Rank: 98
COGT Calmar Ratio Rank: 99
COGT Martin Ratio Rank: 99

VISN

VISN Risk / Return Rank: 99
VISN Sharpe Ratio Rank: 99
VISN Sortino Ratio Rank: 100
VISN Omega Ratio Rank: 99
VISN Calmar Ratio Rank: 100
VISN Martin Ratio Rank: 100

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COGT vs. VISN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cogent Biosciences, Inc. (COGT) and Vistance Networks, Inc (VISN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	COGT	VISN	Difference
Sharpe ratio: Return per unit of total volatility	3.53	5.29	-1.77
Sortino ratio: Return per unit of downside risk	7.68	10.86	-3.18
Omega ratio: Gain probability vs. loss probability	1.90	2.34	-0.44
Calmar ratio: Return relative to maximum drawdown	17.88	48.55	-30.68
Martin ratio: Return relative to average drawdown	44.72	97.42	-52.70
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

COGT vs. VISN - Sharpe Ratio Comparison

The current COGT Sharpe Ratio is 3.53, which is lower than the VISN Sharpe Ratio of 5.29. The chart below compares the historical Sharpe Ratios of COGT and VISN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	COGT	VISN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.53	5.29	-1.77
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.34	0.20	+0.14
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.06	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.02	0.14	-0.17

Drawdowns

COGT vs. VISN - Drawdown Comparison

The maximum COGT drawdown since its inception was -98.09%, roughly equal to the maximum VISN drawdown of -97.95%. Use the drawdown chart below to compare losses from any high point for COGT and VISN.

Drawdown Indicators

	COGT	VISN	Difference
Max Drawdown Largest peak-to-trough decline	-98.09%	-97.95%	-0.14%
Max Drawdown (1Y) Largest decline over 1 year	-25.79%	-16.25%	-9.54%
Max Drawdown (3Y) Largest decline over 3 years	-69.87%	-86.71%	+16.84%
Max Drawdown (5Y) Largest decline over 5 years	-76.34%	-96.04%	+19.70%
Max Drawdown (10Y) Largest decline over 10 years	—	-97.95%	—
Current Drawdown Current decline from peak	-51.91%	-4.57%	-47.34%
Average Drawdown Average peak-to-trough decline	-77.82%	-49.47%	-28.35%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.29%	8.08%	+2.21%

Volatility

COGT vs. VISN - Volatility Comparison

Cogent Biosciences, Inc. (COGT) has a higher volatility of 12.42% compared to Vistance Networks, Inc (VISN) at 9.29%. This indicates that COGT's price experiences larger fluctuations and is considered to be riskier than VISN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	COGT	VISN	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.42%	9.29%	+3.13%
Volatility (6M) Calculated over the trailing 6-month period	31.76%	81.76%	-50.00%
Volatility (1Y) Calculated over the trailing 1-year period	130.68%	149.16%	-18.48%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	95.04%	103.04%	-8.00%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	166.35%	80.72%	+85.63%

Dividends

COGT vs. VISN - Dividend Comparison

COGT has not paid dividends to shareholders, while VISN's dividend yield for the trailing twelve months is around 163.80%.

Position	TTM
COGT Cogent Biosciences, Inc.	0.00%
VISN Vistance Networks, Inc	163.80%

Financials

Frequently Asked Questions

Can I hold both COGT and VISN in my portfolio?

COGT and VISN have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, COGT or VISN?

COGT has higher volatility (12.42%) compared to VISN (9.29%). In terms of maximum drawdown, COGT dropped -98.09% vs VISN's -97.95%.

Which has better risk-adjusted returns?

VISN currently has the higher Sharpe Ratio (5.29 vs 3.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.